The Function of PPARα in Cancer Drug Development: A Promising Target for Cancer Treatment
Cancer is one of the leading causes of mortality globally. PPAR modulators may hold great potential for the management of cancer patients. PPAR modulators also activate specific transcriptional pathways, regulate immune responses and inflammation, and influence the proliferation of various cancer cell types. In the last decade, emerging evidence has shown that PPARα, a nuclear hormone receptor, can modulate carcinogenesis via exerting effects on one or several characteristic pathological behaviors of cancer. This review summarizes current knowledge of PPARα function in various aspects of cancer development and the modulators that regulate PPARα. Based on the current knowledge, we have discussed the development of a potential modulator targeting PPARα for cancer treatment.
Authors
- Ragothaman Prathiviraj (ORCID: https://orcid.org/0000-0002-4747-1374)
- Mohammed Qasim Waheeb (ORCID: https://orcid.org/0000-0001-8938-3666)
- Rasiravathanahalli Kaveriyappan Govindarajan (ORCID: https://orcid.org/0000-0001-7099-0191)
- Igor Rzhepakovsky
- Mohammed A. Al-Duais
- Sergey Povetkin
- Chellasamy Panneerselvam
- Hans-Uwe Dahms
- Abdulrahman Asmari
Institutions
- Kaohsiung Medical University (TW)
- Pondicherry University (IN)
- North-Caucasus Federal University (RU)
- Al-Muthanna University (IQ)
- Karpagam Academy of Higher Education (IN)
- University of Tabuk (SA)
Publication Details
- Journal
- Current Cancer Drug Targets
- Published
- 2026-04-17
- DOI
- https://doi.org/10.2174/0115680096423510251031065737
- Primary Topic
- Peroxisome Proliferator-Activated Receptors
- Type
- article
- Field-Weighted Citation Impact
- 0.00